facebook
twitter
rss
account
search
search
 

Drug may raise bladder cancer risk

Oct. 28, 2009 at 1:10 PM   |   Comments

HANOVER, N.H., Oct. 28 (UPI) -- Taking immune system-suppressing glucocorticoids may raise bladder cancer risk, U.S. researchers said.

The study, published in the British Journal of Cancer, examined the long-term use of glucocorticoids -- drugs used in combination with other drugs to prevent transplanted organ rejection and also to treat diseases such as rheumatoid arthritis and asthma.

Previous research has shown an association between such drug therapies and higher risk of skin cancer and lymphoma. A similar risk for bladder cancer "might indicate the need for closer monitoring of individuals who regularly take glucocorticoids," the study authors said in a statement.

The Dartmouth Medical School research team, led by epidemiologist Margaret Karagas, examined the long-term use of glucocorticoids by 786 bladder-cancer patients and by 1,083 controls.

© 2009 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.
Recommended UPI Stories
Most Popular
1
Daughters more likely than sons to care for elder parents
2
India asks Pepsi to cut down on sugar in its soft drinks
3
Child vaccination rates are high, CDC says
4
Yoga guru BKS Iyengar dies at 95
5
NIH to test safety of Ebola vaccine candidate
Trending News
Video
x
Feedback